Anixa Biosciences Inc (ANIX) earnings date, results and what the price requires
Nasdaq · SEC CIK 0000715446 · SEC filings checked Oct 16, 2026
Next report
Dec 11, 2026
Estimated from reporting history (93-day cycle, SEC periodic report filing dates). Not confirmed.
Last close
$2.67
Polygon.io daily close, Oct 16, 2026. End of day, not live.
Trailing diluted EPS
$-0.31
Sum of quarters ending Jul 31, 2026, Apr 30, 2026, Jan 31, 2026, Oct 31, 2025
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jul 31, 2026 | Sep 9, 2026 | — | $-2.6M | $-0.08 | Filing |
| Apr 30, 2026 | Jun 10, 2026 | — | $-2.5M | $-0.07 | Filing |
| Jan 31, 2026 | Mar 9, 2026 | — | $-2.6M | $-0.08 | Filing |
| Oct 31, 2025 | Jan 12, 2026 | — | $-2.7M | $-0.08 | Filing |
| Jul 31, 2025 | Sep 10, 2025 | — | $-2.3M | $-0.07 | Filing |
| Apr 30, 2025 | May 28, 2025 | — | $-2.8M | $-0.09 | Filing |
| Jan 31, 2025 | Mar 11, 2025 | — | $-3.2M | $-0.10 | Filing |
| Oct 31, 2024 | Jan 10, 2025 | — | $-2.9M | $-0.09 | Filing |
What would Anixa Biosciences Inc have to report for its valuation to change?
Trailing earnings are negative, so a price-to-earnings reverse model does not apply. The model is not shown rather than filled with assumptions.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.